Javascript must be enabled to continue!
Outcome of Early Bi-Level Positive Airway Pressure (BiPAP) Use in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
View through CrossRef
Background: Chronic obstructive pulmonary disease (COPD) is a major global health problem and a leading cause of morbidity and mortality worldwide. Acute exacerbations of COPD frequently result in acute hypercapnic respiratory failure, necessitating ventilatory support. Noninvasive ventilation (NIV), particularly bi-level positive airway pressure (BiPAP), has emerged as a preferred modality during acute exacerbations due to its ability to improve gas exchange, reduce the work of breathing, and decrease the need for invasive mechanical ventilation.
Objective: To determine the outcome of early Bi-level positive airway pressure (BiPAP) use in patients presenting with acute exacerbation of COPD at a tertiary care hospital in Karachi.
Methodology: This prospective observational cohort study was conducted in the Department of Medicine, Abbasi Shaheed Hospital, Karachi, from January 7, 2021, to June 7, 2021. A total of 118 patients aged 30–70 years with a diagnosis of COPD for more than one year, presenting with acute exacerbation and hypercapnic respiratory failure, were enrolled using non-probability consecutive sampling. Early BiPAP therapy was initiated alongside standard medical treatment. Clinical parameters and arterial blood gas values were monitored. Outcomes were categorized as successful or failed based on the need for invasive mechanical ventilation. Data were analyzed using SPSS version 16.
Results: Out of 118 patients, 96 (81.4%) achieved a successful outcome following early BiPAP therapy, while 22 (18.6%) experienced treatment failure. The mean age was 57.87 ± 15.64 years. Significant improvement was observed in post-NIV arterial pH, PaO₂, and PaCO₂ levels. Multivariate analysis demonstrated that post-NIV pH and PaCO₂ were independent predictors of BiPAP success (p < 0.05).
Conclusion: Early initiation of BiPAP in patients with acute exacerbation of COPD was generally well tolerated and associated with a high success rate. This noninvasive strategy has the potential to reduce the need for invasive mechanical ventilation, hospital morbidity, and healthcare costs.
Keywords: Acute COPD Exacerbation, Bi-Level Positive Airway Pressure, Noninvasive Ventilation.
Saidu Medical College
Title: Outcome of Early Bi-Level Positive Airway Pressure (BiPAP) Use in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Description:
Background: Chronic obstructive pulmonary disease (COPD) is a major global health problem and a leading cause of morbidity and mortality worldwide.
Acute exacerbations of COPD frequently result in acute hypercapnic respiratory failure, necessitating ventilatory support.
Noninvasive ventilation (NIV), particularly bi-level positive airway pressure (BiPAP), has emerged as a preferred modality during acute exacerbations due to its ability to improve gas exchange, reduce the work of breathing, and decrease the need for invasive mechanical ventilation.
Objective: To determine the outcome of early Bi-level positive airway pressure (BiPAP) use in patients presenting with acute exacerbation of COPD at a tertiary care hospital in Karachi.
Methodology: This prospective observational cohort study was conducted in the Department of Medicine, Abbasi Shaheed Hospital, Karachi, from January 7, 2021, to June 7, 2021.
A total of 118 patients aged 30–70 years with a diagnosis of COPD for more than one year, presenting with acute exacerbation and hypercapnic respiratory failure, were enrolled using non-probability consecutive sampling.
Early BiPAP therapy was initiated alongside standard medical treatment.
Clinical parameters and arterial blood gas values were monitored.
Outcomes were categorized as successful or failed based on the need for invasive mechanical ventilation.
Data were analyzed using SPSS version 16.
Results: Out of 118 patients, 96 (81.
4%) achieved a successful outcome following early BiPAP therapy, while 22 (18.
6%) experienced treatment failure.
The mean age was 57.
87 ± 15.
64 years.
Significant improvement was observed in post-NIV arterial pH, PaO₂, and PaCO₂ levels.
Multivariate analysis demonstrated that post-NIV pH and PaCO₂ were independent predictors of BiPAP success (p < 0.
05).
Conclusion: Early initiation of BiPAP in patients with acute exacerbation of COPD was generally well tolerated and associated with a high success rate.
This noninvasive strategy has the potential to reduce the need for invasive mechanical ventilation, hospital morbidity, and healthcare costs.
Keywords: Acute COPD Exacerbation, Bi-Level Positive Airway Pressure, Noninvasive Ventilation.
Related Results
CPAP/BiPAP Administration and Cardiac Arrest Events in Hospitalized OSA/OHS Patients
CPAP/BiPAP Administration and Cardiac Arrest Events in Hospitalized OSA/OHS Patients
Abstract
Introduction: Obstructive Sleep Apnea (OSA) and Obesity Hypoventilation Syndrome (OHS) are associated with increased cardiovascular risks and potential c...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Biphasic positive airway pressure in the management of acute respiratory distress syndrome: a comparative study
Biphasic positive airway pressure in the management of acute respiratory distress syndrome: a comparative study
Abstract
Background
Biphasic positive airway pressure, also known as BIPAP, is a type of pressure-controlled ventilation that permits unrestricted s...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Anxiety-depressive syndrome in patients with arterial hypertension and chronic obstructive pulmonary disease with frequent exaccations
Anxiety-depressive syndrome in patients with arterial hypertension and chronic obstructive pulmonary disease with frequent exaccations
Background. In patients with frequent exacerbations of chronic obstructive pulmonary disease occurring against the background of hypertension, there is a high level of personal neu...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

